BOSTON SCIENTIFIC CORP (BSX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2B 4B 6B Q3 '21: 2.9B Q4 '21: 3.1B Q1 '22: 3B Q2 '22: 3.2B Q3 '22: 3.2B Q4 '22: 3.2B Q1 '23: 3.4B Q2 '23: 3.6B Q3 '23: 3.5B Q4 '23: 3.7B Q1 '24: 3.9B Q2 '24: 4.1B Q3 '24: 4.2B Q4 '24: 4.6B Q1 '25: 4.7B Q2 '25: 5.1B Q3 '25: 5.1B Q4 '25: 5.3B Q1 '26: 5.2B Q2 '26: 5.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 1.5B 3B 4.5B Q3 '21: 2B Q4 '21: 2.2B Q1 '22: 2.1B Q2 '22: 2.2B Q3 '22: 2.2B Q4 '22: 2.2B Q1 '23: 2.3B Q2 '23: 2.5B Q3 '23: 2.4B Q4 '23: 2.6B Q1 '24: 2.6B Q2 '24: 2.9B Q3 '24: 2.9B Q4 '24: 3.1B Q1 '25: 3.2B Q2 '25: 3.4B Q3 '25: 3.5B Q4 '25: 3.7B Q1 '26: 3.6B Q2 '26: 3.8B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

0 500M 1B 1.5B Q3 '21: 387M Q4 '21: 180M Q1 '22: 466M Q2 '22: 423M Q3 '22: 358M Q4 '22: 402M Q1 '23: 552M Q2 '23: 514M Q3 '23: 693M Q4 '23: 584M Q1 '24: 675M Q2 '24: 520M Q3 '24: 733M Q4 '24: 675M Q1 '25: 921M Q2 '25: 819M Q3 '25: 1B Q4 '25: 825M Q1 '26: 1.1B Q2 '26: 1.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 500M 1B 1.5B Q3 '21: 419M Q4 '21: 95M Q1 '22: 110M Q2 '22: 260M Q3 '22: 188M Q4 '22: 140M Q1 '23: 314M Q2 '23: 270M Q3 '23: 504M Q4 '23: 504M Q1 '24: 493M Q2 '24: 322M Q3 '24: 468M Q4 '24: 562M Q1 '25: 672M Q2 '25: 795M Q3 '25: 755M Q4 '25: 670M Q1 '26: 1.3B Q2 '26: 905M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 600M 1.2B 1.8B Q3 '21: 900M Q4 '21: 972M Q1 '22: 955M Q2 '22: 1B Q3 '22: 979M Q4 '22: 1B Q1 '23: 1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.1B Q1 '24: 1.2B Q2 '24: 1.3B Q3 '24: 1.3B Q4 '24: 1.5B Q1 '25: 1.5B Q2 '25: 1.6B Q3 '25: 1.5B Q4 '25: 1.6B Q1 '26: 1.6B Q2 '26: 1.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-600M 0 600M 1.2B 1.8B Q3 '21: 465M Q4 '21: 478M Q1 '22: -58M Q2 '22: 307M Q3 '22: 470M Q4 '22: 807M Q1 '23: 190M Q2 '23: 658M Q3 '23: 698M Q4 '23: 957M Q1 '24: 164M Q2 '24: 813M Q3 '24: 1B Q4 '24: 1.5B Q1 '25: 541M Q2 '25: 1.3B Q3 '25: 1.3B Q4 '25: 1.4B Q1 '26: 348M Q2 '26: 1.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-500M 0 500M 1B 1.5B Q3 '21: 358M Q4 '21: 212M Q1 '22: -179M Q2 '22: 202M Q3 '22: 320M Q4 '22: 595M Q1 '23: 79M Q2 '23: 515M Q3 '23: 508M Q4 '23: 690M Q1 '24: -15M Q2 '24: 658M Q3 '24: 823M Q4 '24: 1.2B Q1 '25: 354M Q2 '25: 1.1B Q3 '25: 1.2B Q4 '25: 1B Q1 '26: 171M Q2 '26: 1.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q1 '20: 1.4B Q2 '20: 1.4B Q3 '20: 1.4B Q1 '21: 1.4B Q2 '21: 1.4B Q3 '21: 1.4B Q1 '22: 1.4B Q2 '22: 1.4B Q3 '22: 1.4B Q1 '23: 1.4B Q2 '23: 1.5B Q3 '23: 1.5B Q1 '24: 1.5B Q2 '24: 1.5B Q3 '24: 1.5B Q1 '25: 1.5B Q2 '25: 1.5B Q3 '25: 1.5B Q1 '26: 1.5B Q2 '26: 1.5B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.90 1.80 2.70 Q3 '21: 0.77 Q4 '21: 0.69 Q1 '22: 0.53 Q2 '22: 0.58 Q3 '22: 0.42 Q4 '22: 0.45 Q1 '23: 0.59 Q2 '23: 0.60 Q3 '23: 0.82 Q4 '23: 1.07 Q1 '24: 1.19 Q2 '24: 1.23 Q3 '24: 1.21 Q4 '24: 1.25 Q1 '25: 1.37 Q2 '25: 1.68 Q3 '25: 1.87 Q4 '25: 1.94 Q1 '26: 2.39 Q2 '26: 2.47 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.